81 related articles for article (PubMed ID: 17638424)
21. The expanded double negative T cell populations of a patient with ALPS are not clonally related to CD4+ or to CD8+ T cells.
Marlies A; Udo G; Juergen B; Bernd S; Herrmann M; Haas JP
Autoimmunity; 2007 Jun; 40(4):299-301. PubMed ID: 17516214
[TBL] [Abstract][Full Text] [Related]
22. [Familial splenomegaly as a first clinical sign of autoimmune lymphoproliferative syndrome].
Bilbao Aburto A; Arana Aguirre N; García Martínez JM; Astigarraga Aguirre I; Allende LM
An Pediatr (Barc); 2010 Apr; 72(4):278-81. PubMed ID: 20227933
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune lymphoproliferative syndrome in a patient with a new minimal deletion in the death domain of the FAS gene.
Gualco G; van den Berg A; Koopmans S; Bacchi LM; Carneiro SS; Ruiz E; Vecchi AP; Chan JK
Hum Pathol; 2008 Jan; 39(1):137-41. PubMed ID: 18070632
[TBL] [Abstract][Full Text] [Related]
24. T-gamma-lymphoproliferative disorder arising in a background of autoimmune disease and terminating in plasma cell dyscrasia with primary amyloidosis.
Amparo E; Kaplan L; Rosenbloom B; Lee S
Arch Pathol Lab Med; 1991 Jan; 115(1):74-7. PubMed ID: 1899015
[TBL] [Abstract][Full Text] [Related]
25. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune Lymphoproliferative Syndrome (ALPS) in a Boy with Massive Lymphadenopathy.
Kianifar HR; Khalesi M; Farid R; Badiee Z; Rastin M; Ahanchian H
Iran J Allergy Asthma Immunol; 2010 Sep; 9(3):181-63. PubMed ID: 20952809
[TBL] [Abstract][Full Text] [Related]
27. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
[TBL] [Abstract][Full Text] [Related]
28. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Puck JM; Sneller MC
Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
30. Childhood polyarteritis nodosa in autoimmune lymphoproliferative syndrome.
Naumann-Bartsch N; Stachel D; Morhart P; Staatz G; Jüngert J; Schwarz K; Holter W
Pediatrics; 2010 Jan; 125(1):e169-73. PubMed ID: 20026502
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune lymphoproliferative syndrome; a case report.
Alavi S; Taghi Arzanian M; Chavoshzadeh Z; Esteghamati M
Iran J Allergy Asthma Immunol; 2005 Sep; 4(3):149-52. PubMed ID: 17301439
[TBL] [Abstract][Full Text] [Related]
32. Investigation of suspected deficient Fas-mediated apoptosis in a father and son.
Hanlon MG; Gacis ML; Kakakios AM; Kilham H
Cytometry; 2001 Mar; 43(3):195-8. PubMed ID: 11170106
[TBL] [Abstract][Full Text] [Related]
33. [Results of a series of 104 consecutive bilateral bone marrow biopsy specimens in lymphoproliferative disorders].
Almeida J; García-Marcos MA; Vallejo C; Flores MT; Caballero MD; San Miguel JF; Ríos A
Sangre (Barc); 1995 Oct; 40(5):365-8. PubMed ID: 8553169
[TBL] [Abstract][Full Text] [Related]
34. Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders.
Sands J; Tuscano JM
Autoimmun Rev; 2010 Mar; 9(5):A335-41. PubMed ID: 19914405
[TBL] [Abstract][Full Text] [Related]
35. [Autoimmune lymphoproliferative syndrome: a case report and literature review].
Sun JP; Lu XT; Zhao WH; Hua Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):1022-7. PubMed ID: 26679669
[TBL] [Abstract][Full Text] [Related]
36. Revision of the diagnosis of T-zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II.
van der Werff ten Bosch J; Delabie J; Böhler T; Verschuere J; Thielemans K
Br J Haematol; 1999 Sep; 106(4):1045-8. PubMed ID: 10520011
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune lymphoproliferative syndrome-like syndrome presented as lupus-like syndrome with mycobacterial joint infection evolved into the lymphoma.
Hong YH; Lee CK
Rheumatol Int; 2009 Mar; 29(5):569-73. PubMed ID: 18820932
[TBL] [Abstract][Full Text] [Related]
38. Neonatal Autoimmune Lymphoproliferative Syndrome: A Case Report and A Brief Review.
Chandramati J; Sidharthan N; Ponthenkandath S
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e227-e229. PubMed ID: 32149866
[TBL] [Abstract][Full Text] [Related]
39. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.
Cayrol J; Garrido Colino C
J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735
[TBL] [Abstract][Full Text] [Related]
40. Unexplained lymphadenopathies: autoimmune lymphoproliferative syndrome in an adult patient.
Leal-Seabra F; Costa GS; Coelho HP; Oliveira A
BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 27979843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
